These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6309149)
1. The calcitonin receptor on T 47D breast cancer cells. Evidence for glycosylation. Moseley JM; Findlay DM; Gorman JJ; Michelangeli VP; Martin TJ Biochem J; 1983 Jun; 212(3):609-16. PubMed ID: 6309149 [TBL] [Abstract][Full Text] [Related]
2. Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D). Lamp SJ; Findlay DM; Moseley JM; Martin TJ J Biol Chem; 1981 Dec; 256(23):12269-74. PubMed ID: 6271778 [No Abstract] [Full Text] [Related]
3. Effects of pertussis toxin on adenylate cyclase responses to prostaglandin E2 and calcitonin in human breast cancer cells. Michelangeli VP; Livesey SA; Martin TJ Biochem J; 1984 Dec; 224(2):371-7. PubMed ID: 6097215 [TBL] [Abstract][Full Text] [Related]
4. Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D). Findlay DM; Michelangeli VP; Moseley JM; Martin TJ Biochem J; 1981 May; 196(2):513-20. PubMed ID: 7316992 [TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated gonadotropin action in the ovary. Inhibitory actions of concanavalin A and wheat-germ agglutinin on gonadotropin-stimulated cyclic AMP and progesterone responses in ovarian cells. Azhar S; Menon KM Biochem J; 1981 Oct; 200(1):153-9. PubMed ID: 6277296 [TBL] [Abstract][Full Text] [Related]
6. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin. Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689 [TBL] [Abstract][Full Text] [Related]
7. Effects of lectins and tunicamycin on cAMP response to parathyroid hormone. Rizzoli R; Bonjour JP Am J Physiol; 1989 Jan; 256(1 Pt 1):E80-6. PubMed ID: 2536232 [TBL] [Abstract][Full Text] [Related]
8. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651 [TBL] [Abstract][Full Text] [Related]
9. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells. Ng KW; Livesey SA; Larkins RG; Martin TJ Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157 [TBL] [Abstract][Full Text] [Related]
10. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C; Bawab W; de Cremoux P; Calvo F Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044 [TBL] [Abstract][Full Text] [Related]
11. Relationship between internalization and calcitonin-induced receptor loss in T 47D cells. Findlay DM; Martin TJ Endocrinology; 1984 Jul; 115(1):78-83. PubMed ID: 6329663 [TBL] [Abstract][Full Text] [Related]
12. Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line. Findlay DM; deLuise M; Michelangeli VP; Martin TJ J Endocrinol; 1981 Feb; 88(2):271-81. PubMed ID: 6259268 [TBL] [Abstract][Full Text] [Related]
13. Covalent cross-linking of a photoactive derivative of calcitonin to human breast cancer cell receptors. Moseley JM; Findlay DM; Martin TJ; Gorman JJ J Biol Chem; 1982 May; 257(10):5846-51. PubMed ID: 6121799 [TBL] [Abstract][Full Text] [Related]
14. Identification of multiple human calcitonin receptor isoforms: heterologous expression and pharmacological characterization. Egerton M; Needham M; Evans S; Millest A; Cerillo G; McPheat J; Popplewell M; Johnstone D; Hollis M J Mol Endocrinol; 1995 Apr; 14(2):179-89. PubMed ID: 7619207 [TBL] [Abstract][Full Text] [Related]
15. A mnemonical or negative-co-operativity model for the activation of adenylate cyclase by a common G-protein-coupled calcitonin-gene-related neuropeptide (CGRP)/amylin receptor. Bushfield M; Savage A; Morris NJ; Houslay MD Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):229-36. PubMed ID: 8392334 [TBL] [Abstract][Full Text] [Related]
16. A new in vitro bioassay for human calcitonin: validation and comparison to the rat hypocalcemia bioassay. Grauer A; Raue F; Reinel HH; Schneider HG; Schroth J; Kabay A; Brügger P; Ziegler R Bone Miner; 1992 Apr; 17(1):65-74. PubMed ID: 1316197 [TBL] [Abstract][Full Text] [Related]
17. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line. Hunt NH; Ellison M; Underwood JC; Martin TJ Br J Cancer; 1977 Jun; 35(6):777-84. PubMed ID: 194616 [TBL] [Abstract][Full Text] [Related]
18. cAMP-stimulated adenylate cyclase activation in Dictyostelium discoideum is inhibited by agents acting at the cell surface. Fontana DR; Devreotes PN Dev Biol; 1984 Nov; 106(1):76-82. PubMed ID: 6092179 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of selective activation of cyclic AMP-dependent protein kinase isoenzymes by calcitonin and prostaglandin E2 in human breast cancer cells. Livesey SA; Collier G; Zajac JD; Kemp BE; Martin TJ Biochem J; 1984 Dec; 224(2):361-70. PubMed ID: 6596096 [TBL] [Abstract][Full Text] [Related]
20. Calcitonin receptors in a cloned human breast cancer cell line (MCF 7). Martin TJ; Findlay DM; MacIntyre I; Eisman JA; Michelangeli VP; Moseley JM; Partridge NC Biochem Biophys Res Commun; 1980 Sep; 96(1):150-6. PubMed ID: 6254504 [No Abstract] [Full Text] [Related] [Next] [New Search]